லின் ஷென் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from லின் ஷென். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In லின் ஷென் Today - Breaking & Trending Today

Jacobio Announces First Patient Dosed in Phase I/II Clinical Trial of KRAS G12C Inhibitor for Solid Tumor


Jacobio Announces First Patient Dosed in Phase I/II Clinical Trial of KRAS G12C Inhibitor for Solid Tumor
News provided by
Share this article
Share this article
BEIJING, Aug. 2, 2021 /PRNewswire/ Jacobio Pharmaceuticals (1167.HK) today announced the first patient was dosed in a Phase I/II clinical trial of KRAS G12C inhibitor JAB-21822 in China.
JAB-21822 is Jacobio s innovative in-house small molecule anti-cancer drug, which is designed to target the KRAS G12C mutation. It will be used to treat advanced solid tumors with KRAS G12C mutation, including but not limited to non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and other advanced solid tumors. The global incidence of the KRAS G12C mutation in patients with NSCLC, ovarian cancer, CRC and pancreatic cancer reached approximately 295,000 in 2019.  ....

United States , Lin Shen , Yinxiang Wang , Prnewswire Jacobio Pharmaceuticals , Professor Lin Shen , Beijing Cancer , ஒன்றுபட்டது மாநிலங்களில் , லின் ஷென் , ப்ரொஃபெஸர் லின் ஷென் , பெய்ஜிங் புற்றுநோய் ,

Transcenta Provides Program Update for Anti-Claudin18.2 Monoclonal Antibody TST001 and Reports Promising Early Anti-Tumor Responses in Patients with Gastric Cancer